Scleroderma and scleroderma-like disorders.
D002114:Calcinosis / Q000150:complications; D002276:Carcinoid Tumor / Q000150:complications / Q000556:secondary; D002318:Cardiovascular Diseases / Q000150:complications / Q000188:drug therapy; D004700:Endocrine System Diseases / Q000150:complications; D004802:Eosinophilia / Q000150:complications / Q000473:pathology; D005208:Fasciitis / Q000150:complications / Q000473:pathology; D005385:Fingers; D005767:Gastrointestinal Diseases / Q000150:complications; D006801:Humans; D007674:Kidney Diseases / Q000150:complications; D008113:Liver Neoplasms / Q000150:complications / Q000556:secondary; D008171:Lung Diseases / Q000150:complications; D009059:Mouth Diseases / Q000150:complications; D009135:Muscular Diseases / Q000150:complications; D009422:Nervous System Diseases / Q000150:complications; D011658:Pulmonary Fibrosis / Q000188:drug therapy / Q000473:pathology; D011928:Raynaud Disease / Q000150:complications; D012185:Retroperitoneal Fibrosis / Q000188:drug therapy / Q000473:pathology; D012219:Rheumatology / Q000639:trends; D012594:Scleroderma, Localized / Q000145:classification / Q000150:complications / Q000188:drug therapy / Q000473:pathology*; D012595:Scleroderma, Systemic / Q000145:classification / Q000150:complications / Q000188:drug therapy / Q000473:pathology*; D013577:Syndrome; D013684:Telangiectasis / Q000150:complications; D009626:Terminology as Topic